Literature DB >> 21488161

A novel single point mutation of the LYST gene in two siblings with different phenotypic features of Chediak Higashi syndrome.

Zuhre Kaya1, Stephan Ehl, Meryem Albayrak, Andrea Maul-Pavicic, Klaus Schwarz, Ulker Kocak, Mehmet Ali Ergun, Turkiz Gursel.   

Abstract

Chediak Higashi syndrome (CHS) is an autosomal-recessive disorder characterized by oculocutaneous albinism, recurrent infections and a progressive primary neurological disease. Here, we describe two siblings with CHS due to a novel homozygous R1836X mutation in the LYST gene associated with loss of NK cell degranulation and cytotoxicity. While one sibling was born with fair skin and hair and died of hemophagocytic lymphohistiocytosis (HLH) at 5 months of age, the other sibling had dark black hair and skin and developed HLH at the age of 4 years.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21488161     DOI: 10.1002/pbc.22878

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  11 in total

Review 1.  The BEACH is hot: a LYST of emerging roles for BEACH-domain containing proteins in human disease.

Authors:  Andrew R Cullinane; Alejandro A Schäffer; Marjan Huizing
Journal:  Traffic       Date:  2013-04-24       Impact factor: 6.215

2.  Histiocytic glomerulopathy associated with macrophage activation syndrome.

Authors:  Alfonso Eirin; Maria V Irazabal; Fernando C Fervenza; Sanjeev Sethi
Journal:  Clin Kidney J       Date:  2015-02-17

3.  Chediak-higashi syndrome: a case report of a girl without silvery hair and oculocutaneous albinism presenting with hemophagocytic lymphohistiocytosis.

Authors:  Murat Elevli; Halil Uğur Hatipoğlu; Mahmut Çivilibal; Nilgün Selçuk Duru; Tiraje Celkan
Journal:  Turk J Haematol       Date:  2014-12-05       Impact factor: 1.831

4.  A rare cause of recurrent oral lesions: chediak-higashi syndrome.

Authors:  Müsemma Karabel; Selvi Kelekçi; Velat Sen; Duran Karabel; Ciğdem Aliosmanoğlu; Murat Söker
Journal:  Turk J Haematol       Date:  2014-09-05       Impact factor: 1.831

Review 5.  Towards the targeted management of Chediak-Higashi syndrome.

Authors:  Maria L Lozano; Jose Rivera; Isabel Sánchez-Guiu; Vicente Vicente
Journal:  Orphanet J Rare Dis       Date:  2014-08-18       Impact factor: 4.123

6.  A novel frameshift mutation of Chediak-Higashi syndrome and treatment in the accelerated phase.

Authors:  X L Wu; X Q Zhao; B X Zhang; F Xuan; H M Guo; F T Ma
Journal:  Braz J Med Biol Res       Date:  2017-03-23       Impact factor: 2.590

7.  Differences in Granule Morphology yet Equally Impaired Exocytosis among Cytotoxic T Cells and NK Cells from Chediak-Higashi Syndrome Patients.

Authors:  Samuel C C Chiang; Stephanie M Wood; Bianca Tesi; Himmet Haluk Akar; Waleed Al-Herz; Sandra Ammann; Fatma Burcu Belen; Umran Caliskan; Zühre Kaya; Kai Lehmberg; Turkan Patiroglu; Huseyin Tokgoz; Ayşegül Ünüvar; Wendy J Introne; Jan-Inge Henter; Magnus Nordenskjöld; Hans-Gustaf Ljunggren; Marie Meeths; Stephan Ehl; Konrad Krzewski; Yenan T Bryceson
Journal:  Front Immunol       Date:  2017-04-18       Impact factor: 7.561

8.  Whole Genome Sequencing Identifies Novel Compound Heterozygous Lysosomal Trafficking Regulator Gene Mutations Associated with Autosomal Recessive Chediak-Higashi Syndrome.

Authors:  Yaqiong Jin; Li Zhang; Senfen Wang; Feng Chen; Yang Gu; Enyu Hong; Yongbo Yu; Xin Ni; Yongli Guo; Tieliu Shi; Zigang Xu
Journal:  Sci Rep       Date:  2017-02-01       Impact factor: 4.379

9.  Locating potentially lethal genes using the abnormal distributions of genotypes.

Authors:  Xiaojun Ding; Xiaoshu Zhu
Journal:  Sci Rep       Date:  2019-07-22       Impact factor: 4.379

10.  Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice.

Authors:  Birthe Jessen; Tamara Kögl; Fernando E Sepulveda; Genevieve de Saint Basile; Peter Aichele; Stephan Ehl
Journal:  Front Immunol       Date:  2013-12-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.